Newron Pharma

Newron's Schizophrenia Candidate Scores Mid-Stage Win, Moves to Phase III
BioSpace
Tue, 10/10/23 - 10:11 am
Newron Pharma
clinical trials
evenamide
schizophrenia
Newron’s Schizophrenia Candidate Gets Better Over Time
BioSpace
Fri, 02/17/23 - 09:38 am
Newron Pharma
schizophrenia
evenamide
Newron says pivotal treatment-resistant schizophrenia trial is a go
Pharmaphorum
Tue, 01/3/23 - 10:08 am
Newron Pharma
schizophrenia
evenamide
clinical trials
Newron's Merck KGaA-in licensed compound fails Rett Syndrome study, shares wilt
Endpoints
Mon, 05/4/20 - 10:32 am
Newron Pharma
Merck KGaA
Rett Syndrome
sarizotan
clinical trials
Upcoming events – Obseva's first fibroid foray and Newron's test in Retts
EP Vantage
Fri, 09/6/19 - 10:12 am
clinical trials
ObsEva
uterine fibroids
linzagolix
Newron Pharma
Rett Syndrome
Newron delays pivotal schizophrenia trials amid safety fears
Fierce Biotech
Tue, 05/28/19 - 10:34 am
Newron Pharma
clinical trials
FDA
schizophrenia
evenamide
After an odyssey of setbacks, FDA finally green-lights Newron’s Parkinson’s drug Xadago
Endpoints
Wed, 03/22/17 - 11:11 am
FDA
Newron Pharma
Parkinson's Disease
Xadago
safinamide
Newron faces further FDA delay for Parkinson's drug as regulator demands addiction evidence
Fierce Biotech
Wed, 03/30/16 - 11:00 am
Newron Pharma
FDA
Parkinson's Disease
Xadago
Swiss Biotech IPOs May Revive Industry Starved of Investment
Bloomberg
Thu, 07/7/11 - 10:15 pm
IPOs
Roche
Novartis
Actelion
Molecular Partners
Newron Pharma
Switzerland
Newron, Merck Serono conclude patient recruitment in Phase III MOTION study
Pharmaceutical Business Review
Wed, 06/29/11 - 07:30 am
Newron Pharma
Merck Serono
Parkinson's Disease
Biotech's Latest Business Mishaps
Seeking Alpha
Mon, 05/10/10 - 09:19 am
Abbott Laboratories
Bristol-Myers Squibb
GSK
InterMune
JNJ
Merck
Pfizer
Newron Pharma
Dainippon Sumitomo